M H Maor
Overview
Explore the profile of M H Maor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
883
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Levin V, Yung W, BRUNER J, Kyritsis A, LEEDS N, Gleason M, et al.
Int J Radiat Oncol Biol Phys
. 2002 May;
53(1):58-66.
PMID: 12007942
Purpose: To conduct a Phase II one-arm study to evaluate the long-term efficacy and safety of accelerated fractionated radiotherapy combined with i.v. carboplatin for patients with previously untreated anaplastic gliomas....
2.
Kumar A, Leeds N, Fuller G, Van Tassel P, Maor M, Sawaya R, et al.
Radiology
. 2000 Nov;
217(2):377-84.
PMID: 11058631
Purpose: To describe both the common and less frequently encountered magnetic resonance (MR) imaging features of radiation therapy- and chemotherapy-induced brain injury, with particular emphasis on radiation necrosis. Materials And...
3.
Maor M, Dubey P, Tucker S, Shiu A, Mathur B, Sawaya R, et al.
Int J Cancer
. 2000 Jul;
90(3):157-62.
PMID: 10900428
This study was conducted to determine prognostic factors for tumor response and patient survival after stereotactic radiosurgery (SRS) for brain metastasis. Eighty-four patients with brain metastasis underwent SRS at a...
4.
Groves M, Maor M, Meyers C, Kyritsis A, Jaeckle K, Yung W, et al.
Int J Radiat Oncol Biol Phys
. 1999 Sep;
45(1):127-35.
PMID: 10477016
Purpose: To conduct a Phase II study to evaluate the long-term efficacy and safety of high-dose 5'-bromodeoxyuridine (BrdU) and accelerated radiotherapy followed by procarbazine, lomustine (CCNU), and vincristine (PCV) chemotherapy...
5.
Givens S, Woo S, Huang L, Rich T, Maor M, Cangir A, et al.
Int J Oncol
. 1999 May;
14(6):1039-43.
PMID: 10339654
Eighty-five patients (37 female, 48 male; median age 14 years) with non-metastatic Ewing's sarcoma received definitive treatment at the University of Texas M.D. Anderson Cancer Center between 1969 and 1988....
6.
Nguyen L, Maor M, Oswald M
Cancer
. 1998 Nov;
83(10):2181-4.
PMID: 9827723
Background: The prognosis of patients with brain metastasis as the only manifestation of an undetected primary tumor generally is considered to be poor. Therefore, most treatment is palliative. The authors...
7.
Maor M, NORTH L, Cabanillas F, Ames A, Hess M, Cox J
Int J Radiat Oncol Biol Phys
. 1998 Jul;
41(3):647-50.
PMID: 9635715
Purpose: To review the long-term clinical effects of unilateral kidney irradiation on overall renal function and blood pressure in patients with gastric lymphoma. Methods And Materials: In the study were...
8.
Wronski M, Maor M, Davis B, Sawaya R, Levin V
Int J Radiat Oncol Biol Phys
. 1997 Mar;
37(4):753-9.
PMID: 9128947
Purpose: Approximately 10% of patients with metastatic renal cell carcinoma are diagnosed with brain metastases. Most of these patients receive palliative radiotherapy and die of progressive brain metastatic disease. This...
9.
Shiu A, Kooy H, Ewton J, Tung S, Wong J, Antes K, et al.
Int J Radiat Oncol Biol Phys
. 1997 Feb;
37(3):679-88.
PMID: 9112467
Purpose: A prototype Miniature Multi-Leaf Collimator (MMLC) designed specifically for radiosurgery and small field radiotherapy has been fabricated and evaluated at the University of Texas M. D. Anderson Cancer Center...
10.
Maor M
J Neurooncol
. 1996 Sep;
29(3):261-7.
PMID: 8858532
Because of a substantial overall recurrence rate of meningiomas, the role of surgery as the sole treatment for every case must be evaluated. Also, occasionally, the patient's age and/or the...